Showing 1 - 8 results of 8 for search 'P.U. Cameron', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ART by J. Symons, C. Bacchus-Souffan, A. Chopra, S. Leary, D. Cameron, P.U. Cameron, R. Hoh, H. Ahn, S.G. Deeks, J.M. McCune, S. Mallal, P.W. Hunt, S.R. Lewin
Published 2019Connect to this object online.
Book -
7
23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal by T.M. Mota, G. Khoury, J.C. Jacobson, H.K. Lu, F. Wightman, d.e.r. Sluis, J.L. Anderson, P.U. Cameron, S.R. Lewin, D.F.J. Purcell, R.M. Van
Published 2016Connect to this object online.
Book -
8
The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial by J. Symons, S.F.L. van Lelyveld, W. de Spiegelaere, A.M.J. Wensing, J. Drylewicz, A.I.M. Hoepelman, P.U. Cameron, H. Lu, T. Mota, A.I. Dantanarayana, L. Vandekerckhove, S.R. Lewin, K. Tesselaar, M. Nijhuis
Published 2017Connect to this object online.
Book